Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

Pujol JL, Lavole A, Quoix E, Molinier O, Souquet PJ, Barlesi F, Le Caer H, Moro-Sibilot D, Fournel P, Oster JP, Chatellain P, Barre P, Jeannin G, Mourlanette P, Derollez M, Herman D, Renault A, Dayen C, Lamy PJ, Langlais A, Morin F, Zalcman G; French Cooperative Thoracic Intergroup (IFCT); French Cooperative Thoracic Intergroup IFCT.

Ann Oncol. 2015 Feb 16. pii: mdv065. [Epub ahead of print]

PMID:
25688059
2.

Perceptions of plain packaging among young adult roll-your-own smokers in France: a naturalistic approach.

Gallopel-Morvan K, Moodie C, Eker F, Beguinot E, Martinet Y.

Tob Control. 2015 Mar;24(e1):e39-44. doi: 10.1136/tobaccocontrol-2013-051513. Epub 2014 Jun 11.

PMID:
24920573
3.

[Evaluation of requests for a second medical opinion by patients with lung cancer].

Zysman M, Clément-Duchène C, Nguyen-Thi PL, Carnin C, Martinet Y.

Rev Mal Respir. 2014 May;31(5):412-20. doi: 10.1016/j.rmr.2013.09.004. Epub 2013 Oct 18. French.

PMID:
24878157
4.

[The tobacco industry against the new European directive on tobacco products].

Martinet Y, Béguinot E.

Rev Prat. 2014 Feb;64(2):156-8. French. No abstract available.

PMID:
24701865
5.

Is there a relationship between the presence of lung mucosa preinvasive lesions and lung cancer incidence? Influence of tobacco consumption.

Clément-Duchêne C, Alla F, Gauchotte G, Marie B, Carnin C, Menard O, Vignaud JM, Martinet Y.

Lung Cancer. 2014 May;84(2):134-8. doi: 10.1016/j.lungcan.2014.02.003. Epub 2014 Feb 16.

PMID:
24589076
6.

Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.

Quoix E, Westeel V, Moreau L, Pichon E, Lavolé A, Dauba J, Debieuvre D, Souquet PJ, Bigay-Game L, Dansin E, Poudenx M, Molinier O, Vaylet F, Moro-Sibilot D, Herman D, Sennelart H, Tredaniel J, Mennecier B, Morin F, Baudrin L, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique.

Eur Respir J. 2014 Jan;43(1):240-9. doi: 10.1183/09031936.00048213. Epub 2013 Oct 10.

PMID:
24114964
7.

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial).

Ramalingam S, Crawford J, Chang A, Manegold C, Perez-Soler R, Douillard JY, Thatcher N, Barlesi F, Owonikoko T, Wang Y, Pultar P, Zhu J, Malik R, Giaccone G; FORTIS-M Study Investigators.

Ann Oncol. 2013 Nov;24(11):2875-80. doi: 10.1093/annonc/mdt371. Epub 2013 Sep 19.

8.

[Inadequate secretion of β-human chorionic gonadotropin in lung cancer].

Godbert B, Tiotiu A, Masias C, Martinet Y.

Rev Pneumol Clin. 2013 Oct;69(5):298-301. doi: 10.1016/j.pneumo.2013.04.005. Epub 2013 Sep 12. French.

PMID:
24035551
9.

Diffuse pulmonary ossification in a patient exposed to silica.

Jungmann H, Godbert B, Wissler MP, Regent D, Vignaud JM, Bavelele Z, Martinet Y.

Eur Respir Rev. 2013 Jun 1;22(128):189-90. doi: 10.1183/09059180.00004312. No abstract available.

10.

Efficacy of a smoking cessation program in a population of adolescent smokers in vocational schools: a public health evaluative controlled study.

Minary L, Cambon L, Martini H, Wirth N, Acouetey DS, Thouvenot F, Maire C, Martinet Y, Bohadana A, Zmirou-Navier D, Alla F.

BMC Public Health. 2013 Feb 18;13:149. doi: 10.1186/1471-2458-13-149.

11.

[Hospitalization: an important opportunity to treat addiction to tobacco smoke].

Wirth N, Martinet Y.

Rev Mal Respir. 2012 Sep;29(7):851-2. doi: 10.1016/j.rmr.2012.07.002. Epub 2012 Aug 4. French. No abstract available.

PMID:
22980543
12.

A combination of smears and cell block preparations provides high diagnostic accuracy for endobronchial ultrasound-guided transbronchial needle aspiration.

Gauchotte G, Vignaud JM, Ménard O, Wissler MP, Martinet Y, Siat J, Paris C, Clément-Duchêne C.

Virchows Arch. 2012 Nov;461(5):505-12. doi: 10.1007/s00428-012-1296-x. Epub 2012 Aug 16.

PMID:
22895864
13.

[Nicotine, a killing faker].

Martinet Y, Wirth N.

Rev Mal Respir. 2012 Apr;29(4):445-7. doi: 10.1016/j.rmr.2012.02.006. Epub 2012 Mar 23. French. No abstract available.

PMID:
22542403
14.

Progressive lung cancer determined by expression profiling and transcriptional regulation.

Han N, Dol Z, Vasieva O, Hyde R, Liloglou T, Raji O, Brambilla E, Brambilla C, Martinet Y, Sozzi G, Risch A, Montuenga LM; EUELC Consortium, Brass A, Field JK.

Int J Oncol. 2012 Jul;41(1):242-52. doi: 10.3892/ijo.2012.1421. Epub 2012 Mar 28.

PMID:
22469662
15.

Occupational risk factors have to be considered in the definition of high-risk lung cancer populations.

Wild P, Gonzalez M, Bourgkard E, Courouble N, Clément-Duchêne C, Martinet Y, Févotte J, Paris C.

Br J Cancer. 2012 Mar 27;106(7):1346-52. doi: 10.1038/bjc.2012.75.

16.

[Anti-angiogenic agents in the treatment of lung cancer: indications and toxicities].

Clément-Duchêne C, Godbert B, Martinet Y.

Rev Mal Respir. 2012 Feb;29(2):161-77. doi: 10.1016/j.rmr.2011.06.017. Epub 2012 Jan 4. Review. French.

PMID:
22405111
17.

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators.

N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898.

18.

Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.

Scoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, Timsit JF, Tavecchio L, Brambilla C, Field JK, Hainaut P; European Early Lung Cancer Consortium.

Eur Respir J. 2012 Jul;40(1):177-84. doi: 10.1183/09031936.00097311. Epub 2012 Jan 20.

19.

Giant cell interstitial pneumonia: report of two cases with high titanium concentration in the lung.

Paris C, Pairon JC, Billon-Galland MA, Vanoni-Espiand H, Godbert B, Martinet Y, Chabot F, Aymard B, Vignaud JM.

Am J Respir Crit Care Med. 2011 Dec 1;184(11):1315-7. No abstract available.

PMID:
22162891
20.

Smoking, occupational risk factors, and bronchial tumor location: a possible impact for lung cancer computed tomography scan screening.

Gonzalez M, Vignaud JM, Clement-Duchene C, Luc A, Wild P, Bertrand O, Thiberville L, Martinet Y, Benichou J, Paris C.

J Thorac Oncol. 2012 Jan;7(1):128-36. doi: 10.1097/JTO.0b013e318233d7a6.

PMID:
22031233
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk